AZ's Imfinzi on target in small cell lung cancer, sets up Roche rivalry - pharmaphorum
AZ's Imfinzi on target in small cell lung cancer, sets up Roche rivalry pharmaphorum
AstraZeneca's Imfinzi cancer immunotherapy has hit the mark in phase 3 trial in extensive-stage small cell lung cancer.
Comments
Post a Comment